18 Jan

The Undrugging of Annie (Part I)

It is a large, square, clear plastic Rubbermaid container with a blue-rimmed lid, and it is full of pills.  Red pills, brown pills, white pills.  Capsules and packed powder.  Round and oval.  Large, medium and small.  Gray pills, yellow pills, blue pills.  Half a gallon of pills.

            I take it to Dr. Ghaly, the psychiatrist and acupuncturist, and he looks aghast.  “What is this?” he cries.  “What is this?”

            “These are all the pills I was taking when I stopped taking pills,” I tell him.  His eyes wide with amazement, he grabs the container and races out of the room.  When he comes back, he tells me he went to weigh it.  There are two and a half pounds of pills.

            I take them to Dr. Cohen, the psychologist and hypnotherapist.  He looks at them awfully and says, “Where did these come from?”

            “When I came home from the hospital,” I say, “I took the bottles full of all the pills I was taking.  I put the bottles in a basket, the basket in a bag, the bag in a carton, and the carton in the closet.  Last week I needed the basket to plant pansy seeds, so my aide emptied all the bottles into this container.”
            I take the container to Dr. Wechsler, the chiropractor and ayurvedic practitioner.  “Who gave you these?” he asks.

            “The doctors,” I say.  “These were all prescribed by physicians.  I was taking them all at the same time.”

            “What are you going to do with them?”

            “I dunno.  Maybe sort them out by color, layer them in an apothecary jar—strata of disaster, you know?—then permanently seal the apothecary jar and put it on display as testament to—well, to something.”

            I take the lid off, pick up handfuls of pills, and let them slide through my fingers.

            Dr. Wechsler looks sick and cries, “Don’t!  The toxins will be absorbed through your skin!”

            In 1974, a neurologist, a pastor, and a social worker with terminal cancer formed “Alethea:  The Center on Death and Dying” in Syracuse, New York.  Their avowed concerns were that Americans were denying grief or treating it as pathological, and that there was a need to develop a healthy acceptance of a normal mourning process.  I participated in a lengthy course to train grief counselors.

            On Thanksgiving Day, I went for a walk before dinner and mailed a letter to my beloved—a Marine Corps fighter pilot—saying that I would join him on base as soon as I could make arrangements.  Before he received the letter, his plane crashed.  He ejected but his parachute did not open.  I missed the last Alethea meeting because I was in New York City burying my heart, my soul, my hope, my future, my everything.

            Several months later, I went to the neurologist complaining of fatigue, lethargy, and lack of spontaneous movement.  He said I was depressed and had a history of what he called “endogenous depression.”  He dealt with the depressive phase of my mourning by prescribing drugs, specifically, the antidepressant Elavil.  When the prescription ran out, I would call his office.  Around seven o’clock the next morning, he would wake me with a phone call.  We would talk for a few minutes, then he would mail me a new prescription for a thirty-day supply, with twelve refills.  We did that for several years, then I moved on to a psychiatrist who prescribed more drugs.

            I was handed from one psychiatrist to another, each altering the antidepressant prescription, until I ended up with Dr. Jenifer Rich.  She continued the drugging.  I was a good girl, and totally committed to the idea that my life depended on drugs.  One day in group therapy we were asked what three things we would want if we were stranded on a desert island.  I was the only person who said I wanted my medication.  I was a believer.

            No matter what was done in the way of therapy or antidepressants, I continued to cycle through what was now called major depression, severe and recurrent.  There were occasional suicide attempts and several hospitalizations each year that would last four or five days.  I went to the National Institute of Mental Health and they recommended a monoamine oxidase inhibitor.  Dr. Rich went to a conference and the chief of psychiatry at Stanford University recommended a combination of lithium and an antidepressant.

            I took 1500 mg. of lithium every day for seven years, plus an antidepressant and such other drugs as Dr. Rich ordered.  When it reached the point that I was getting up four or five times every night to urinate, I insisted—against Dr. Rich’s wishes—that she refer me to another psychiatrist for evaluation.  He recommended that she do the kidney function tests that she should have been doing every six months, but had never done.

            I was diagnosed with nephrogenic diabetes insipidus (NDI), a rare incurable kidney disease that is usually caused by bad doctors prescribing lithium.  NDI causes urine output to increase—in my case, the increase was five times normal.  I quit the doctor and the lithium.

When I went to the next psychiatrist, it turned out I also had cardiac irregularities caused by the lithium.  When I went to the lawyer, I discovered that dozens of my other physical complaints, ranging from shortness of breath to my fingers turning black, were side effects of the lithium.  I saw three lawyers and each refused to take the case.  One said that in our county, juries hated malpractice suits and liked psychiatric malpractice suits even less; another said that my case would only settle for about $70,000, “and, frankly, we were looking for a windfall.”

            The treatment for nephrogenic diabetes insipidus is DDAVP, which costs $10,000 a year, and hydrochlorathiazide (HCTZ), which causes potassium depletion, so I took DDAVP and HCTZ, and got hypokalemia.  Potassium supplements were added to complete the drug package.  (To be continued)

18 Jan

Just add turmeric and clear away those Blue Monday blues

Happy 2011 to you! I know it’s a little late to be well wishing for 2011 but usually for me, January is about collecting my thoughts, tying loose ends (especially taxes!), planning the year ahead and reflecting on the past. Every year I find I need a couple of weeks after the holidays to think, reflect and get my ducks in a row to start the year off on a good note.

This time, there was a whole decade to reflect upon!

No more blue Mondays this winter! Just add turmeric.

Already with two weeks into the new decade, I’m sure you’ve heard it all on resolutions, how to change your life in 30 days, diet fixers and so much more. Come every January we’re bombarded with new workout plans, the latest and greatest tips to lose weight and advice on how to become a happier person.

And why not? As we age, isn’t every year to be improved from the last as we grow wiser, learn and reflect on past experiences and let go of what we thought was important to focus on the real things that truly make us happy? Of course it is.

Continue Reading »

17 Jan

Blues Begone-on-line CBT without a therapist

Blues Begone is an on-line CBT resource available for you to purchase and do at home in your own time.

David Purves, the psychologist who has developed the programme says;

Depression isn’t something that you can just ‘snap out of’. The most effective form of treatment is Cognitive Behavioral Therapy (CBT), which is the approach that Blues BeGone uses.

Up until now CBT has only been available face-to-face from therapists, but this is often difficult or impossible to get when you need it, and can be expensive. Blues BeGone tackles these problems as it lets you treat yourself with proven CBT, developed by a qualified and experienced Chartered Psychologist, by computer when and where you need it. Careful research has shown that it is as effective as both face to face therapy and anti-depressant drugs.  Start to get better now and beat the blues.

I spoke with David a while back and I am fortunate to have trialled this programme. After receiving many, many CBT sessions myself and talking from experience, I recommend Blues Begone as an affordable alternative if you are unable to get talking therapies via your GP straight away.

In addition to the on-line programme, you get regular email support and guidance to help with your depression and anxiety.

Depression Alliance has carried out research on the programme-the results here.

Press release here

17 Jan

Study reveals top ten violence-inducing prescription drugs

As most who read this know-I would tend toward a more conspiratorial view of this. Our government has often experimented on us with drugs and I suspect they have known about this.  http://www.naturalnews.com/029946_government_conspiracy_medical_experiments.html

Notice that the smoking cessation drug Chantix is # 1 and that the US and local governments have been HEAVILY pushing people to stop smoking through their heavy handed criminalization of smoking everywhere even in people’s own homes. http://www.mercurynews.com/bay-area-news/ci_16417771?source=rss&nclick_check=1

Don’t think for 1 minute that they do not want an increase in violence as an excuse to further restrict your rights and freedoms. (E) http://www.truthandliberty.com/ProblemReactionSolution.html and http://ephraiyim.wordpress.com/the-problem-reaction-solution-paradigm-why-911-happened/

Here is the PLOS research article:  http://www.plosone.org/article/info:doi/10.1371/journal.pone.0015337

drug

Saturday, January 15, 2011 by: Ethan A. Huff, staff writer

 

(NaturalNews) The Institute for Safe Medication Practices (ISMP) recently published a study in the journalPLoS Onehighlighting the worst prescription drug offenders that cause patients to become violent. Among the top-ten most dangerous are the antidepressants Pristiq (desvenlafaxine), Paxil (paroxetine) and Prozac (fluoxetine).

Concerns about the extreme negative side effects of many popular antidepressant and antipsychotic drugs have been on the rise, as these drugs not only cause severe health problems to users, but also pose a significant threat to society. The ISMP report indicates that, according to the U.S. Food and Drug Administration‘s (FDA) Adverse Event Reporting System, many popular drugs are linked even to homicides.

Most of the drugs in the top ten most dangerous are antidepressants, but also included are an insomnia medication, an attention-deficit hyperactivity disorder (ADHD) drug, a malaria drug and an anti-smoking medication.

As reported inTime, the top ten list is as follows:

10. Desvenlafaxine (Pristiq) – An antidepressant that affects serotonin and noradrenaline. The drug is        7.9 times more likely to be associated withviolencethan other drugs.

9. Venlafaxine (Effexor) – An antidepressant that treats anxiety disorders. The drug is 8.3 times more     likely to be associated with violence than other drugs.

8. Fluvoxamine (Luvox) – A selective serotonin reuptake inhibitor (SSRI) drug that is 8.4 times more       likely to be associated with violence than other drugs.

7. Triazolam (Halcion) – A benzodiazepine drug for insomnia that is 8.7 times more likely to be                   associated with violence than other drugs.

6. Atomoxetine (Strattera) – An ADHD drug that is 9 times more likely to be associated with violence       than other drugs.

5. Mefoquine (Lariam) – A malaria drug that is 9.5 times more likely to be associated with violence           than other drugs.

4. Amphetamines – This general class of ADHD drug is 9.6 times more likely to be associated with             violence than other drugs.

3. Paroxetine (Paxil) – An SSRI antidepressant drug that is 10.3 times more likely to be associated            with violence than other drugs. It is also linked to severe withdrawal symptoms and birth defects.

2. Fluoxetine (Prozac) – A popular SSRI antidepressant drug that is 10.9 times more likely to be               associated with violence than other drugs.

1. Varenicline (Chantix) – An anti-smoking drug that is a shocking 18 times more likely to be                       associated with violence than other drugs.

Sources for this story include:

http://healthland.time.com/2011/01/…

 

 

15 Jan

Service vs. Power

It is Easter and I hurt.  The Neurontin must be increased but even so I doubt that it will do any good.  Bipolar II depression is supposed to be treated with a mood stabilizer and a mood elevator, i.e., an antidepressant.  There are no more antidepressants I can use.  Also, we have eliminated four of the five stabilizers, therefore, Neurontin is all we’ve got with which to work.  And I’ve been feeling lousy most of the last two weeks.  Maybe we’re just not increasing the Neurontin fast enough.  Or maybe we’re trying to use a stabilizer as an elevator.

            Some good things happened today—one or two moments here and there—but I don’t feel like talking about them because . . . I don’t know, maybe because it’ll make me cry.

            I woke up at 5:30 a.m.  Bad pain in my shoulder.  Took Tylenol.  Took orange juice in the event of low blood sugar.  Went back to bed and cried.  Took Ativan.  Slept, finally.  Was awakened for church.  Felt terrible.  Didn’t know whether to get up or not.  Got up.  Shouldn’t have.

            Went to church.  Drank Ensure.  Cried.  Got took home.  By Steve.  Ate leftover Chinese.  Slept for nearly three hours.  Came back to hospital and cried.  Watched movie.  Talked to Mom.  Cried.  Guess I’m pretty depressed.

            Tomorrow’s my 103rd day in captivity.  [I had been on inpatient psychiatry at St. Joseph’s Hospital for 103 days because they couldn’t find any place to discharge me.  I had both physical and mental illness, and no care facility would accept both.]  Appointment with Paul.  Big deal.  Dr. Ghaly was supposed to do acupuncture for my shoulder last Friday.  He forgot.  Saturday he said he’d do it but didn’t show up.

Tomorrow?  I will no longer have Nicole from Physical Therapy as part of my health care team.  And if I were not in a hospital—on a psychotic unit?—would she dare speak to me the way she does anyway?  And if I was not in a hospital then I would be getting better medical care.  Hospitals are for acute care.  I have been here 103 days and need routine follow-up care for chronic illnesses.  I am not getting that care.

            For example, I was suffering from diabetes mellitus II, controlled by diet.  I routinely took my blood sugar, it routinely averaged out to about 100, and I routinely saw my doctor at the Joslin Clinic.  Then I was admitted to Intensive Care, my blood sugar went up to an unspecified level, and I was put on insulin injections.  After being admitted to the psychiatric unit, finger-sticks were done on a regular basis, my blood sugar levels dropped, and I was taken off insulin and put on Glucophage.

After more time passed—and because I, and I alone, was paying attention to my glucose levels—the internist was called again and I was taken off medication and left to control my diabetes with diet again.  Then we started me on the Neurontin—ah, screw all this.  I’m just getting myself worked up.  The bottom line simply is that the internist considers himself too busy to follow me, the nurses—ah, crap.  Just understand this:  No routine medical care takes place on an inpatient basis.

            My vision has gotten very, very, scary bad—and nobody listens and nobody does a damn thing about it.  Fuck everybody.

Addendum  What I would not learn until years later is that inpatient psychiatry is not under the jurisdiction of the NYS Dept. of Health.  All those medical things over which the Dept. of Health has jurisdiction do not apply to inpatient psychiatry.

Inpatient psychiatry is under the jurisdiction of the NYS Office of Mental Health.

Psychiatric units imbedded in hospitals such as St. Joseph’s, Upstate Medical Center and Community General are, in fact, not hospitals in the traditional medical sense. State psychiatric “hospitals,” such as Hutchings Psychiatric Center, are not hospitals at all.  If you need medical evaluation at Hutchings, you are trucked down the street to Upstate Medical Center’s emergency room.

I am “dual diagnosis,” i.e., I have both bipolar depression and multiple physical illnesses, most resulting from improper drug treatment of depression.  On inpatient psychiatry I cannot get a food tray brought to my bed, or my wheelchair pushed, or help with a shower, because those are considered to be medical issues.

Mental health counselors—the college graduates who provide direct patient care on inpatient psychiatry—are not trained to give showers.  They are the first line of reporting for patients—many of whom are elderly and disabled—about medical problems and they have no medical training.

After I got off a month on life support, I was returned to inpatient psychiatry.  I was forbidden to get out of bed because I was too weak to stand or walk.  One morning the staff didn’t bring me my breakfast tray or any liquids.  I have a rare kidney disease called nephrogenic diabetes insipidus; it was caused by unmonitored lithium.  It has broken down my kidneys so that I urinate constantly, even when I’m not drinking.  Several times a year I would dehydrate and end up in the Emergency Room.

So there I was on inpatient psychiatry at St. Joseph’s Hospital, too sick to get out of bed and not getting any liquids.  I recognized the symptoms and realized that I was slowly dehydrating into a coma.  I ran the bell.  Jennifer the aide came.  Knowing nothing at all about my illness, she judged me and found me immoral:  she decided I was faking.  She refused to bring me “any liquids until you ask nicely.”  When I wanted the bell to call a nurse, Jennifer took it out of my reach.  Slowly lapsing into unconsciousness, I was at the mercy of a judgmental girl with no medical training.

Years later I applied for a job at Onondaga Case Management but got shot down.  Jennifer was on the committee making the hiring decision.

Psychiatric treatment is not dispensed on the basis of service to sick people.  It is based on power over weak people.

15 Jan

Study reveals top ten violence-inducing prescription drugs

Saturday, January 15, 2011 by: Ethan A. Huff

The Institute for Safe Medication Practices (ISMP) recently published a study in the journalPLoS Onehighlighting the worst prescription drug offenders that cause patients to become violent. Among the top-ten most dangerous are the antidepressants Pristiq (desvenlafaxine), Paxil (paroxetine) and Prozac (fluoxetine).

Concerns about the extreme negative side effects of many popular antidepressant and antipsychotic drugs have been on the rise, as these drugs not only cause severehealthproblems to users, but also pose a significant threat to society. The ISMP report indicates that, according to the U.S. Food and Drug Administration‘s (FDA) Adverse Event Reporting System, many populardrugsare linked even to homicides.

Most of the drugs in the top ten most dangerous are antidepressants, but also included are aninsomniamedication, an attention-deficit hyperactivitydisorder(ADHD) drug, a malariadrugand an anti-smoking medication.

As reported inTime, the top ten list is as follows:

10. Desvenlafaxine (Pristiq) – An antidepressant that affects serotonin and noradrenaline. The drug is 7.9 times more likely to be associated withviolencethan other drugs.

9. Venlafaxine (Effexor) – An antidepressant that treats anxiety disorders. The drug is 8.3 times more likely to be associated with violence than other drugs.

8. Fluvoxamine (Luvox) – A selective serotonin reuptake inhibitor (SSRI) drug that is 8.4 times more likely to be associated with violence than other drugs.

7. Triazolam (Halcion) – A benzodiazepine drug for insomnia that is 8.7 times more likely to be associated with violence than other drugs.

6. Atomoxetine (Strattera) – An ADHD drug that is 9 times more likely to be associated with violence than other drugs.

5. Mefoquine (Lariam) – A malaria drug that is 9.5 times more likely to be associated with violence than other drugs.

4. Amphetamines – This general class of ADHD drug is 9.6 times more likely to be associated with violence than other drugs.

3. Paroxetine (Paxil) – An SSRIantidepressant drugthat is 10.3 times more likely to be associated with violence than other drugs. It is also linked to severe withdrawal symptoms and birth defects.

2. Fluoxetine (Prozac) – A popular SSRI antidepressant drug that is 10.9 times more likely to be associated with violence than other drugs.

1. Varenicline (Chantix) – An anti-smoking drug that is a shocking 18 times more likely to be associated with violence than other drugs.

Sources for this story include:

http://healthland.time.com/2011/01/…

Learn more:http://www.naturalnews.com/031017_violence_prescription_drugs.html#ixzz1B8aMYYO7

14 Jan

Relapse from antidepressant medication may be lack of response to medication

Study suggests that loss of depression treatment response is likely due to loss of placebo response.

A new study by Rhode Island Hospital researchers indicates that a relapse during antidepressant continuation treatment may be due to a relapse in patients who were not true drug responders. The loss of drug response may be due to loss of placebo response (a positive medical response to taking a placebo as if it were an active medication.). The study was published in the August issue of the Journal of Clinical Psychiatry.

Historically, the treatment of depression is divided into three phases � � ” initial/acute, continuation and maintenance. During the initial phase, the goal is to reduce symptoms and psychosocial impairment. During the continuation phase, usually six months to one year after initial treatment response, the goal is to maintain the gains and prevent a relapse. In the maintenance phase, which occurs after a sustained period of improvement, the goal is to further maintain the gains and prevent recurrence of the disorder.

Mark Zimmerman, MD, director of outpatient psychiatry at Rhode Island Hospital and associate professor of psychiatry and human behavior at the Warren Alpert School of Medicine at Brown University, is the paper’s lead author. Zimmerman, along with his colleague Tavi Thongy, MD, also of Rhode Island Hospital and Brown University, conducted a meta-analysis of continuation studies of new generation antidepressants that began as placebo-controlled acute phase studies. Treatment studies of depression have found that approximately 50 to 65 percent of patients respond to medication and that approximately 25 to 35 percent respond to placebo.

Past studies have indicated that a number of patients who respond to treatment in the initial phase experience a relapse or recurrence despite ongoing pharmacotherapy during the two latter phases of treatment. This return of symptoms is often interpreted as a loss of efficacy of antidepressant activity, and is referred to as tachyphylaxis or the “poop-out” effect.

Zimmerman says, “When a patient improves after being prescribed an antidepressant medication you do not know if they got better because of the medication or because they had a placebo response.”

The researchers used formulas developed by Quitkin and colleagues more than a decade ago to calculate the relapse rate attributable to relapse in presumptive placebo responders. “Our study suggests that the return of symptoms despite ongoing treatment during the continuation and maintenance phases of treatment may not represent a loss of drug effect because the patient may not have experienced a true drug response in the first place.”

Zimmerman also notes, “While our conclusion is limited to the continuation phase of treatment, our results suggest that these findings probably also apply to the maintenance phase of treatment.”

The researchers note that these findings are not inconsistent with conclusions that continuation and maintenance studies of antidepressants have clearly established the benefit of ongoing treatment beyond the acute phase.

14 Jan

DepressionEfficacy Of Vagus Nerve Stimulation For Treatment-Resistant Depression

Treatment-Resistant Depression

Medical University of South Carolina announced the results of a functional MRI (fMRI) study examining the effects of VNS (Vagus Nerve Stimulation) Therapy for patients with treatment-resistant depression (TRD).

The study, led by Ziad Nahas, M.D., associate professor, MUSC Department of Psychiatry, appears in the August 2007 issue of peer-reviewed Neuropsychopharmacology. The results show that VNS Therapy modulates areas of the brain that control mood. The researchers also identified variables, such as length of use, strength of stimulation and level of depression, to better understand the impact of VNS Therapy.

“These data provide further insight into VNS therapy’s distinct mechanism of action and support its previously demonstrated long-term, sustained efficacy,” Nahas said. “We are encouraged to see the unique benefit VNS therapy may bring to patients with one of the most difficult-to-treat forms of depression and are excited to continue neurostimulation research at MUSC.”

The study illustrates that VNS Therapy modifies activity of the medial prefrontal cortex, the same area of the brain targeted by many antidepressant medications and electroconvulsive therapy (ECT). A critical time for such effective modulation occurs approximately at 30 weeks of treatment. Such modulation could support VNS Therapy’s unique mechanism of action as a long- term treatment for chronic or recurrent depression and directly corresponds with the timeframe in which patients typically experience a decrease in symptoms. Further analysis of the data demonstrates that modulation of the brain is a dynamic process that over time leads to indirectly related improved response with continued use. These findings corroborate an earlier MUSC-led study that revealed approximately two-thirds of patients who respond to VNS Therapy continue to experience significant clinical benefit at 24 months, making VNS Therapy the only treatment for TRD to demonstrate such long-term improvements.

The FDA approved VNS therapy in 2005 as an adjunctive long-term treatment of chronic or recurrent depression for patients (18 years of age or older) who are experiencing a major depressive episode and have not had an adequate response to four or more antidepressant treatments. It is the only device ever studied and approved for treatment-resistant depression. VNS therapy is delivered from a small pacemaker-like device implanted in the chest area that sends mild pulses to the brain via the vagus nerve in the neck.

Nahas’ esteemed colleague Mark S. George, M.D., MUSC Departments of Psychiatry, Neurology and Radiology, shares this vision and supports the need for additional research to maximize the potential of neurostimulation as a diagnostic and therapeutic agent. George has launched a new international, peer-reviewed journal that is dedicated to exploring the field of neuromodulation. Published by Elsevier, Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation strives to provide the most comprehensive collection of research being conducted in this emerging field. As editor-in-chief, George’s extensive experience researching neurostimulation applications will aide him in facilitating and shaping the field’s promising future.

12 Jan

Anti depressants that are linked to VIOLENCE? - Desvenlafaxine (Pristiq), Venlafaxine (Effexor), Fluvoxamine (Luvox), Triazolam (Halcion), Atomoxetine (Strattera), Mefoquine (Lariam), Amphetamines: (Various), Paroxetine (Paxil), Fluoxetine (Prozac), Varenicline (Chantix)

Some really popular drugs on here.

This is the outcome of a generation that has no ethics or morals and no personal convictions.  This is the result of 40 years of people abdicating personal responsibility and having no consequences for bad behavior.  You can’t even say BAD behavior.  Nothing is BAD.  Personal, self control is completely absent from these people.

The communist and progressives want a population of sheep and this is definitely a great weapon at their disposal.   They can even mandate it for some school children.  Those who become too disruptive need “focusing” medications, so that they can “concentrate.” They will not be readmitted to a class without seeing a therapist.  If they are not put on medication, then the school rejects the findings of that “doctor” and tells the kid that they need to find another doctor that would “help” them “better” as this treatment or analysis didn’t work out or didn’t seem to be “correct.” The school would like a 2nd opinion.  Then, they recommend one of there own.  THAT scenario is right out of Soviet Russia.  THAT is being done here.  The faces of EVIL.  There is a truth to the idea that one becomes that which one HATES.

 

 

 

Top Ten Legal Drugs Linked to Violence

By Maia Szalavitz Friday, January 7, 2011 | 160 comments

When people consider the connections between drugs and violence, what typically comes to mind are illegal drugs like crack cocaine. However, certain medications — most notably, some antidepressants like Prozac — have also been linked to increase risk for violent, even homicidal behavior.

A new study from the Institute for Safe Medication Practices published in the journal PloS One and based on data from the FDA’s Adverse Event Reporting System has identified 31 drugs that are disproportionately linked with reports of violent behavior towards others. (More on Time.com: New Hope For An Anti-Cocaine Vaccine)

Please note that this does not necessarily mean that these drugs cause violent behavior. For example, in the case of opioid pain medications like Oxycontin, people with a prior history of violent behavior may seek  drugs in order to sustain an addiction, which they support via predatory crime. In the case of antipsychotics, the drugs may be given in an attempt to reduce violence by people suffering from schizophrenia and other psychotic disorders — so the drugs here might not be causing violence, but could be linked with it because they’re used to try to stop it.

Nonetheless, when one particular drug in a class of nonaddictive drugs used to treat the same problem stands out, that suggests caution: unless the drug is being used to treat radically different groups of people, that drug may actually be the problem. Researchers calculated a ratio of risk for each drug compared to the others in the database, adjusting for various relevant factors that could create misleading comparisons.  Here are the top ten offenders:

10. Desvenlafaxine (Pristiq) An antidepressant which affects both serotonin and noradrenaline, this drug is 7.9 times more likely to be associated with violence than other drugs.

9. Venlafaxine (Effexor) A drug related to Pristiq in the same class of antidepressants, both are also used to treat anxiety disorders. Effexor is 8.3 times more likely than other drugs to be related to violent behavior. (More on Time.com: Adderall May Not Make You Smarter, But It Makes You Think You Are)

8. Fluvoxamine (Luvox) An antidepressant that affects serotonin (SSRI), Luvox is 8.4 times more likely than other medications to be linked with violence

7. Triazolam (Halcion) A benzodiazepine which can be addictive, used to treat insomnia. Halcion is 8.7 times more likely to be linked with violence than other drugs, according to the study.

6) Atomoxetine (Strattera) Used to treat attention-deficit hyperactivity disorder (ADHD), Strattera affects the neurotransmitter noradrenaline and is 9 times more likely to be linked with violence compared to the average medication.

5) Mefoquine (Lariam) A treatment for malaria, Lariam has long been linked with reports of bizarre behavior. It is 9.5 times more likely to be linked with violence than other drugs.

4) Amphetamines: (Various) Amphetamines are used to treat ADHD and affect the brain’s dopamine and noradrenaline systems. They are 9.6 times more likely to be linked to violence, compared to other drugs.

3) Paroxetine (Paxil) An SSRI antidepressant, Paxil is also linked with more severe withdrawal symptoms and a greater risk of birth defects compared to other medications in that class. It is 10.3 times more likely to be linked with violence compared to other drugs. (More on Time.com: Healthland’s Guide to Life 2011)

2) Fluoxetine (Prozac) The first well-known SSRI antidepressant, Prozac is 10.9 times more likely to be linked with violence in comparison with other medications.

1) Varenicline (Chantix) The anti-smoking medication Chantix affects the nicotinic acetylcholine receptor, which helps reduce craving for smoking. Unfortunately, it’s 18 times more likely to be linked with violence compared to other drugs — by comparison, that number for Xyban is 3.9 and just 1.9 for nicotine replacement. Because Chantix is slightly superior in terms of quit rates in comparison to other drugs, it shouldn’t necessarily be ruled out as an option for those trying to quit, however.

Related Links:

Read more: http://healthland.time.com/2011/01/07/top-ten-legal-drugs-linked-to-violence/#ixzz1ArKF5z5w

 

12 Jan

Stroke someone today and make them smile!

Last night I was working on an assignment for my Life coaching course and a section I particularly d